|
General Information
|
|
|
Product
|
EHD2 Peptide
|
|
Description
|
Antigenic Blocking Peptide EH domain-containing protein 2 Antibody
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide taken within amino acid 420-450 on human EH-Domain Containing Protein 2.
|
|
Accession #
|
NCBI: NP_055416.2
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q9NZN4
|
|
Overview
|
Plays a role in membrane reorganization in response to nucleotide hydrolysis
|
|
Molecular Function
|
ATP binding;GTPase activity;nucleic acid binding;calcium ion binding;GTP binding
|
|
Subcellular Location
|
Cell membrane, Endosome, Membrane
|
|
Expression
|
Highly expressed in heart and moderately expressed in placenta, lung, and skeletal muscle.
|
|
Structure
|
Homodimer and homooligomer. Interacts with EHD1 and MYOF. May also interact with EHD3 and EHD4.
|
|
Alternative Nomenclature
|
EH domain containing 2 antibody
EH domain containing 3 antibody
EHD 2 antibody
EHD3 antibody
FLJ96617 antibody
PAST 2 antibody
|
| |
|
EHD2 Antibody
EHD2 Antibody FITC
EHD2 Antibody BIOTIN
EHD2 Positive Control
